Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation ; volume:10 ; number:1 ; day:21 ; month:7 ; year:2010 ; pages:1-12 ; date:12.2010
BMC cancer ; 10, Heft 1 (21.7.2010), 1-12, 12.2010
- Urheber
-
Gotfryd, Kamil
- Beteiligte Personen und Organisationen
-
Skladchikova, Galina
Lepekhin, Eugene A.
Berezin, Vladimir
Bock, Elisabeth
Walmod, Peter S.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-383
- URN
-
urn:nbn:de:1111-2016030358144
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gotfryd, Kamil
- Skladchikova, Galina
- Lepekhin, Eugene A.
- Berezin, Vladimir
- Bock, Elisabeth
- Walmod, Peter S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells
Influence of the HDAC inhibitor Valproic acid on the growth and proliferation of Temsirolimus-resistant prostate cancer cells in vitro
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation
Wound healing effects of Asparagus lucidus Lindl extract through the phosphorylation of ERK1/2
Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
Phosphorylation of astrocytic connexin43 by ERK1/2 impairs blood–brain barrier in acute cerebral ischemia
Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth
Social support rescues acute stress-induced cognitive impairments by modulating ERK1/2 phosphorylation in adolescent mice
Entwicklung von Klasse I/IIb Histondeacetylase (HDAC)-inhibitoren und HDAC-PROTACs
Mechanistische Untersuchung der regulatorischen ERK-Thr188-Phosphorylierung in ERK1/2-vermittelter kardialer Hypertrophie : = Mechanistic investigation of regulatory ERK Thr188 phosphorylation in ERK1/2-mediated cardiac hypertrophy
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells
Influence of the HDAC inhibitor Valproic acid on the growth and proliferation of Temsirolimus-resistant prostate cancer cells in vitro
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation
Wound healing effects of Asparagus lucidus Lindl extract through the phosphorylation of ERK1/2
Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
Phosphorylation of astrocytic connexin43 by ERK1/2 impairs blood–brain barrier in acute cerebral ischemia
Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth
Social support rescues acute stress-induced cognitive impairments by modulating ERK1/2 phosphorylation in adolescent mice
Entwicklung von Klasse I/IIb Histondeacetylase (HDAC)-inhibitoren und HDAC-PROTACs
Mechanistische Untersuchung der regulatorischen ERK-Thr188-Phosphorylierung in ERK1/2-vermittelter kardialer Hypertrophie : = Mechanistic investigation of regulatory ERK Thr188 phosphorylation in ERK1/2-mediated cardiac hypertrophy
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells
Influence of the HDAC inhibitor Valproic acid on the growth and proliferation of Temsirolimus-resistant prostate cancer cells in vitro
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation
Wound healing effects of Asparagus lucidus Lindl extract through the phosphorylation of ERK1/2
Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
Phosphorylation of astrocytic connexin43 by ERK1/2 impairs blood–brain barrier in acute cerebral ischemia
Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth
Social support rescues acute stress-induced cognitive impairments by modulating ERK1/2 phosphorylation in adolescent mice
Entwicklung von Klasse I/IIb Histondeacetylase (HDAC)-inhibitoren und HDAC-PROTACs